期刊文献+

2014-2015年536例尿培养病原菌分布及耐药性分析

Distribution and antibiotic resistance of pathogenic bacteria isolated from 536 urine specimens during 2014~2015
下载PDF
导出
摘要 目的:了解医院2014-2015年尿病原菌分布和耐药性.方法:对2014-2015年我院所有尿培养检出的病原菌进行统计分析.结果:共检出病原菌536株,革兰阴性(G-)菌398株,占74.3%,革兰阳性(G+)菌110株,占20.5%,真菌28株,占5.2%.检出率前5位的是大肠埃希菌(38.8%,208/536)、 屎肠球菌(8.4%,45/536)、 肺炎克雷伯菌(8.2%,44/536)、凝固酶阴性葡萄球菌(6.1%,33/536)和铜绿假单胞菌(6.0%,32/536).碳青酶烯类抗菌药对大肠埃希菌和肺炎克雷伯菌抗菌活性最强,对铜绿假单胞菌抗菌活性较差;革兰阳性球菌对糖肽类和利奈唑胺抗菌药物高度敏感.结论:尿培养分离的病原菌菌种复杂、 耐药情况严重,临床应积极开展病原菌分布及其耐药性监测,及时调整抗菌药物. Objective: This study aims to investigate the distribution and antibiotic resistance of common bacteria isolated from urine culture samples collected from 2014 to 2015. Methods: Distribution and antibiotic resistance of pathogens in 536 urine culture-positive patients from 2014 to2015 were analyzed. Results: Pathogenic strains isolated from 536 patients were collected from the urine specimens in this survey, which includs 398 (74.3%) strains of Gram-negative bacilli, 110 (20.5%) strains of Gram-positive cocci and 28 (5.2%) strains of fungi. The top five pathogens were Escherichia coli (38.8%, 208/536) , Enterococcn faecium (8.4%, 45/536) , Klebsiella pneumoniae (8.2~/O, 44/536 ) , coagulase negative staphylococci (6.1%, 33/536) , and Pseudomonas aemginosa (6.0%, 32/536) . Carbopenems showed the most anfimicrobial activity to E. coli and K. p neumoniae, but the susceptibility ofP. aeruginosa to carbopenems reduced. Gram-positive cocci were highly sensitive to glycopeptides and linezolick Conclusion: Bacterial species isolated from urine cultures diversified and the antibiotic resistance is serious. Distribution of the pathogenic bacteria and their drug resistance should be monitored continuously, which could modify treatment timely.
出处 《医学检验与临床》 2017年第9期25-29,共5页 Medical Laboratory Science and Clinics
关键词 尿培养 病原菌 耐药性 抗菌药物 Urine culture Pathogenic bacteria Drug resistance Antibiotics
  • 相关文献

参考文献6

二级参考文献66

  • 1谢志祥.尿路感染病原菌的分布及耐药性分析[J].中华医院感染学杂志,2004,14(4):471-472. 被引量:51
  • 2叶应妩,王毓三.全国临床检验操作规程[M].3版.南京:东南大学出版社.2007:472-531. 被引量:20
  • 3Clinical and Laboratory Standads Institute. Performance Standards for Antimicrobial Susceptibility Testing [S J . Sixteenth Informational Supplement. 2012 .M100-S22. 被引量:1
  • 4Tygacil (tigecycline) iv injection label - US FDA [S]. 2013. Reference ID: 3379756. http://www. accessdata. fda. gov/ drugsatfda_docs/labeI/2013 /021821 s026s031lbl. pdf. 被引量:1
  • 5Clinical and Laboratory Standads Institute. Performance Standards for Antimicrobial Susceptibility Testing [S J . Sixteenth Informational Supplement. 2011 ? M100-S21. 被引量:1
  • 6Tsai YK. Liou CH. Fung CPo et al. Single or in combination antimicrobial resistance mechanisms of Klebsiella pneumoniae contribute to varied susceptibility to different carbapenems [J]. PLoS One. 2013:8(11): e79640. 被引量:1
  • 7van Duin D. Kaye KS. Neuner EA. et aI. Carbapenem-resistant Enterobacteriaceae: a review of treatment and outcomes[J]. Diagn Microbiol Infect Dis. 2013.75(2): 115-120. 被引量:1
  • 8Zarkotou O. Pournaras S. Altouvas G. et al. Comparative evaluation of tigecyciine testing methods for expandedspectrum cephalosporin and carbapenem-resistant gramnegative pathogens [J]. J Clin Microbiol , 2012. 50 (11) : 3747-3750. 被引量:1
  • 9Huang TD. Berhin C. Bogaerts P. et al. In vitro susceptibility of multidrug-resistant Enterobacteriaceae clinical isolates to tiyecyciine[J]. J Antimicrob Chemother , 2012. 67 (11): 2696-2699. 被引量:1
  • 10Ronald A.The etiology of urinary tract infection:traditional and emerging pathogens[J].Am J Med,2002,113(suppl1A):S14-19. 被引量:1

共引文献80

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部